November 27, 2021
This post provides a navigational drilldown of the website titled “COVID-19 early treatment: real-time analysis of 1,160 studies” looking specifically at Ivermectin COVID-19 research studies, systematic reviews, meta-analyses, theory/safety and news articles.
In the 130 Ivermectin studies, eighty-five of the studies were peer reviewed with sixty-seven studies compared treatment with control groups receiving no treatment. The Front Line COVID-19 Critical Care Alliance (FLCCC) contributes providing treatment recommendations.
The Ivermectin studies are searchable within the following categories; All, Early, Late and Prophylaxis usage. Further search methods include “inclusion criteria, effect extraction criteria (more serious outcomes have priority), PRISMA” (evidence-based minimum set of reporting items in systematic reviews and meta-analyses) “answers, and statistical methods”.
Access the Ivermectin for Covid 19 Realtime Meta-Analysis of 67 Studies here
Access the explanation of treatment stage here
Access results by treatment stage
Access Randomized Controlled Trials (RCT) here
-
- RCT participants receiving Ivermection are chosen randomly from an eligible population
- RCT control group participants receive no Ivermectin are chosen randomly from the same eligible population.
ACCESS explanation of Heterogeneity Causing variability in studies
Access Analysis of WHO, Merck and FDA use of the published studies here
